1. The Influence of Anti-Diabetic Drugs on Prostate Cancer
   Miłosz Knura et al, 2021, Cancers CrossRef
2. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer
   Shouru Zhang et al, 2015, Medical Oncology CrossRef
3. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment
   Shuixian Li et al, 2016, Biomedicine & Pharmacotherapy CrossRef
4. Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis
   Qiujun Guo et al, 2016, BioMed Research International CrossRef
5. Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes
   Li-Chiung Lin et al, 2017, Cancer Letters CrossRef
6. Mixtures of persistent organic pollutants increase ovarian granulosa tumor cell line migration and spheroid invasion by upregulating MMP2 expression and activity via IGF1R
   Justyna Gogola-Mruk et al, 2021, Toxicology CrossRef
7. The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis
   Zhenhua Zhang et al, 2019, BMC Cancer CrossRef
8. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer
   Kiran Bharat Lokhande et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
9. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
   Chin-Hsiao Tseng, 2023, Frontiers in Endocrinology CrossRef
10. C5a stimulates the proliferation of breast cancer cells via Akt-dependent RGC-32 gene activation
    YI LU et al, 2014, Oncology Reports CrossRef
11. Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells
    Deok-Soo Han et al, 2022, Scientific Reports CrossRef
12. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer
    Dansaem Lim et al, 2020, BMB Reports CrossRef
13. Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
    Takako Kawakita et al, 2017, Experimental and Therapeutic Medicine CrossRef
14. The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: A review and meta-analysis
    Moumita Nath et al, 2021, Meta Gene CrossRef
15. RETRACTED ARTICLE: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis
    Jianwei Tian et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
16. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ
    Virginie Ory et al, 2018, Breast Cancer Research and Treatment CrossRef
17. An HCG-rich microenvironment contributes to ovarian cancer cell differentiation into endothelioid cells in a three-dimensional culture system
    MIN SU et al, 2015, Oncology Reports CrossRef
18. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
    Pedro Miguel Lacal et al, 2018, Pharmacological Research CrossRef
19. Downregulation of Astrocyte Elevated Gene-1 Expression Combined with All-Trans Retinoic Acid Inhibits Development of Vasculogenic Mimicry and Angiogenesis in Glioma
    Chen Liang et al, 2022, Current Medical Science CrossRef
20. Research Progress of PPARγ in Prostate Cancer
    耀 常, 2023, Advances in Clinical Medicine CrossRef